Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/15/14 → 04/2/17 |
Funding
- Medpace Inc: $4,500.00
ARGOS: An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
- Adler, Howard (CoPI)
- Darras, Frank (CoPI)
- Waltzer, Wayne (CoPI)
- Wu, Shenhong (CoPI)
- Corcoran, Anthony (PI)
- Fitzgerald, John (CoPI)
- Galanakis, Dennis (CoPI)
- Mishail, Alek (CoPI)
Project: Research